EU Clinical Trial 2017-003364-12

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer  Mar 5, 2019

Main objective of the trial: To evaluate the effectiveness of niraparib plus AA-P compared to AA-P plus placebo.

Parties

Sponsors